France Sclerotherapy Market Size, Share, and COVID-19 Impact Analysis, By Agents (Detergents, Chemical Irritants, Osmotic Agents), By Type (Ultrasound Sclerotherapy, Foam Sclerotherapy), and France Sclerotherapy Market Insights, Industry Trend, Forecasts to 2035

France Sclerotherapy Market Insights Forecasts to 2035 

• The France Sclerotherapy Market Size was estimated at USD 21.5 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 5.24% from 2025 to 2035
• The France Sclerotherapy Market Size is Expected to Reach USD 37.7 Million by 2035

According to a research report published by Spherical Insights & Consulting, the France Sclerotherapy Market is anticipated to reach USD 37.7 million by 2035, growing at a CAGR of 5.24% from 2025 to 2035. This is because the market is driven by the rising incidence of venous diseases that impact a large percentage of the population, such as varicose veins and chronic venous insufficiency.

Market Overview 

The France sclerotherapy market refers to the economic space made of the sale of products and services in relation to the medical procedure sclerotherapy. Sclerotherapy refers to the procedure of injecting a solution into abnormal veins (various veins and spider veins) under a fine-gauge needle so the veins will be rendered unrecognizable, as these curl, collapse, and fade. The sclerotherapy market includes the sale of the sclerosants (solutions for injection), syringes, needles, and the professional services provided by healthcare variety of healthcare practitioners who inject vessels, performing the sclerotherapy procedure. The rise in venous diseases like chronic venous insufficiency and varicose veins is boosting the market, as these conditions affect a large population. Patients are looking for effective and minimally invasive treatments that can treat their medical symptoms and improve their cosmetic appearance as well. Developments in techniques and sclerosants will only continue to drive growth in the market for sclerotherapy, improving the effectiveness and safety of the treatment. With changes to healthcare systems, the availability of these treatments will continue to improve, which will definitely contribute to the sclerotherapy industry's growth. These factors are therefore additionally feeding growth in the sclerotherapy market.

Report Coverage

This research report categorizes the France sclerotherapy market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France sclerotherapy market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France sclerotherapy market. 

Driving Factors

The France sclerotherapy market is primarily driven by the rising prevalence of varicose veins and spider veins, technological advancements in minimally invasive procedures, and increasing demand for aesthetic procedures. In addition to these factors, increasing healthcare expenditure and improving access to advanced treatments are also drivers.

Restraining Factors

The France sclerotherapy market faces several challenges, including high treatment costs, potential side effects, a lack of awareness, and regulatory hurdles. Additionally, the availability of alternative treatments and the need for specialized expertise also pose challenges.

Market Segmentation

The France sclerotherapy market share is classified into agents and type.

• The detergents segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The France sclerotherapy market is segmented by agents into detergents, chemical irritants, and osmotic agents. Among these, the detergents segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is because of their established safety record and effectiveness as sclerosing agents. It is commonly known that detergents can successfully irritate the vein wall, resulting in the closure of varicose veins and other venous disorders.  Their credibility among medical professionals is further increased by the FDA's approval, which promotes broad clinical practice adoption.

• The foam sclerotherapy segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The France sclerotherapy market is segmented by type into ultrasound sclerotherapy, foam sclerotherapy. Among these, the foam sclerotherapy segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is ascribed to its efficacious treatment of larger veins.  Compared to conventional liquid sclerosants, foam formulations offer superior visibility and contact with the vein wall, enhancing the effectiveness of treatment. The use of foam sclerotherapy has increased due to patients' increasing preference for less invasive procedures.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France sclerotherapy market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. 

List of Key Companies

• Troikaa
• Omega Pharmaceuticals Pvt. Ltd.
• Viatris Inc.
• AngioDynamics
• Perrigo Company plc
• Merz Pharma
• Medtronic
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the France Sclerotherapy Market based on the below-mentioned segments:

France Sclerotherapy Market, By Agents                                                         

• Detergents
• Chemical Irritants
• Osmotic Agents

France Sclerotherapy Market, By Type                    

• Ultrasound Sclerotherapy
• Foam Sclerotherapy